MedTrace Logo

Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance Myography

NCT01803386 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2015-07-22

No results posted yet for this study

Summary

The purpose of this protocol is to test a new Electrical Impedance Myography (EIM) device and study its reliability and ability to differentiate ALS patients from healthy controls.

Conditions

  • Amyotrophic Lateral Sclerosis (ALS)

Interventions

DEVICE

EIM Measurements

EIM measurements are taken by applying saline to the skin and placing a sensor on patients' muscles that will record electrical activity. Electrical current is generated by this machine, but patients will not be able to feel it. The electrical activity recorded is returned to the machine and analyzed by a computer.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • Skulpt, Inc.

    lead INDUSTRY

Principal Investigators

  • Erik Ensrud, MD · VA Boston Healthcare System

Eligibility

Min Age
21 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01803386 on ClinicalTrials.gov